Skip to main content
SAM CHUN DANG PHARM CO. LTD logo

SAM CHUN DANG PHARM CO. LTD — Investor Relations & Filings

Ticker · 000250 ISIN · KR7000250001 KO Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2021-11-01 Regulatory Filings
Country KR South Korea
Listing KO 000250

About SAM CHUN DANG PHARM CO. LTD

http://www.scd.co.kr/english/scd/index.…

SAM CHUN DANG PHARM CO. LTD. is a pharmaceutical company focused on the development, manufacturing, and sale of medications. The company specializes in ophthalmic products, establishing itself as a significant player in the generic eye care market. Its portfolio also extends to other therapeutic areas, including antibiotics and medications for the circulatory system. The company produces a range of ethical (prescription) and over-the-counter (OTC) drugs in both sterile and non-sterile forms. Manufacturing operations adhere to international quality standards, holding both US and EU Good Manufacturing Practice (GMP) certifications.

Recent filings

Filing Released Lang Actions
풍문또는보도에대한해명(미확정)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Clarification of Rumors or Reports' (풍문 또는 보도에 대한 해명). It addresses specific media reports about the company's investment activities and clinical trials. Since it is a general regulatory announcement regarding corporate rumors and does not fit into specific categories like M&A, earnings, or dividends, it is classified as a Regulatory Filing (RNS).
2021-11-01 Korean
기타경영사항(특허권취득)(자율공시)(안과용 약학 조성물)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from Samchundang Pharm regarding the acquisition of a patent for an ophthalmic pharmaceutical composition. It is a voluntary disclosure (자율공시) of a specific corporate event (patent acquisition) rather than a financial report, management change, or shareholder meeting material. Since it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2021-10-15 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding an upcoming Investor Relations (IR) event (Non-deal Roadshow). It provides details such as the date, location, purpose, and topics to be discussed, and explicitly mentions that the IR materials will be made available on the date of the event. Since this is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the category of a regulatory filing announcement regarding corporate activities.
2021-10-12 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Samchundang Pharm Co., Ltd. for the period from January 1, 2021, to June 30, 2021. It contains comprehensive financial data, business operations, management discussions, and financial statements, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
[기재정정]전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Samchundang Pharm regarding the adjustment of the conversion price of convertible bonds. It details the recalculation of the conversion price due to a calculation error in the previous filing. This type of disclosure, which relates to changes in capital structure and financial instruments (convertible bonds), falls under the 'Capital/Financing Update' category.
2021-08-17 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Clarification of Rumors or Reports' (풍문 또는 보도에 대한 해명). It addresses specific media reports about investment attraction and provides updates on business negotiations. Since it is a regulatory announcement regarding company news and does not fit into specific categories like financial reports or shareholder meetings, it is classified as a general regulatory filing.
2021-08-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.